Claim Missing Document
Check
Articles

Found 2 Documents
Search

Formulasi nanoemulsi gel minyak daun cengkeh (Syzygium Aromaticum L.) Merr. & Perry) dan uji aktivitas anti-acne Desi Alviolina; Yulia Kusumanti; Meity Christiani
Journal of Pharmaceutical and Sciences Vol 4 No 2 (2021): JPS Volume 4 Nomor 2 (2021)
Publisher : Fakultas Farmasi Universitas Tjut Nyak Dhien

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36490/journal-jps.com.v4i2.169

Abstract

Background: The most common skin disease worldwide is acne (acne vulgaris); acne is a chronic inflammatory disease in the pilosebaceous unit. The main factors affecting acne are increased sebum production, keratinocyte secretion, bacterial growth, and inflammation. The objective was to study the physical properties of clove gel (Syzygium aromaticum (L.) Merr. and L.M.). Perry)..Research Objectives: The purpose of this study is to develop nanoemulsion products containing clove oil that have good physical properties and stability.Method: This type of research is experimental and conducted in a medical laboratory. This study evaluated the physical properties of the gel, such as organoleptic evaluation, homogeneity, pH, stickiness, spreadability, and viscosity. In addition, the antibacterial effectiveness test was also carried out, which then determined at what concentration the essential oil could be used as a substitute for antibacterial gels on the market. Results: Results and Discussion The research began with choosing eugenol from clove leaf oil, which acts as an active ingredient in the gel composition. This identification was carried out to ensure that the essential oil used in making the gel in this study contains eugenol, which has been shown to have antibacterial effects in previous studies. Conclusion: Based on the research conducted, it can be concluded that the preparation of Nanoemulsion containing 5% clove oil with 30% Tween 80 as surfactant and 15% PEG 400 as additional surfactant of pharmaceutical requirements, including organoleptic test, homogeneity, pH measurement, viscosity, rheology, lubrication, measure of permeability value, sphere size, PDI value
Profil Penggunaan Antibiotik dan Peta Kuman Pasien Gangrene Diabetes Melitus Di RSUD Adam Malik Tahun 2022 Eldesi Medisa Ilmawati; Mila Febrina Rindayani; Desi Alviolina; Lili Yuliana Tambunan
Journal of Pharmaceutical and Sciences Vol 5 No 2 (2022): JPS Volume 5 Nomor 2 (2022)
Publisher : Fakultas Farmasi Universitas Tjut Nyak Dhien

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36490/journal-jps.com.v5i2.154

Abstract

Background: Diabetes is a chronic disease caused by the inability of the pancreas to produce enough insulin, and leads to elevated blood glucose. Diabetes carries the risk of complications and is life-threatening if not properly managed. Diabetes is one of the top ten causes of death worldwide. Diabetics have a 25% risk of developing complications due to diabetic foot infections caused by bacteria. Foot infections in diabetics can be fatal. Objective: To determine the profile of antibiotic use and spore map in diabetic gangrene patients at Adam Malik Hospital. Method: This study is a type of quasi-experimental research with a Pretest Posttest Nonequivalent Control Group, in which this design, the experimental group and the control group are not randomly selected; namely, this design is carried out before and after treatment. Results: In this study, culture tests were performed on 54 patients (44%), with positive results in 34 patients and negative results in 20 patients. The most common bacteria was Enterobacter cloacae at 24%, which is a gram-negative bacteria, followed by Escherichia coli, Staphylococcus aureus, Acinetobacter baumannii, Pseudomonas aeruginosa, Citrobacter youngae, Enterobacter aerogenes, Proteusphylocferi vulgai. Proteus mirabilis were 18%, 15%, 9%, 6%, 6%, 6%, 6%, 3% and 3% respectively. Conclusion: The results showed that metronidazole infusion was the most widely used antibiotic quantitatively, namely. 286.03 DDD/100 treatments per patient day.